CD28 and cancer: After activation and expansion of epitope specific memory CD8+ T cells (effector cells) through peptide mixture and anti-CD28 antibody, we first detected the effects of cytotoxic CD8+ T cells on the 4T1-turbo cell line by using an optimal ratio of target cancer cells to effector cells (4-5:1).